News and Topics
Featured News
Public engagement is key to building momentum for longevity science, and you can make a real difference. Our nonprofit team works hard to bring you the latest news in the field. Please consider making a donation to support our work. Thank You.
Today, Forever Healthy announces the launch of a set of new tools to make it easier than ever for AI agents,
A new study suggests that aging or Parkinson’s-triggering mutations create inflammation in peripheral tissues, and then circulating extracellular vesicles spread it
In this follow-up interview, we speak with Gabriel Cian about how the 2060 ecosystem has evolved since last year’s Forum, what
A new study associated with Immorta Bio suggests that combining a senolytic vaccine with mesenchymal stem cells might create a synergistic
A perspective published in Aging and Disease has recommended the use of underground laboratory space in order to remove the effects
Scientists have linked disrupted Ca²⁺ homeostasis to aging in both progeroid and naturally aging mice. Rescuing it with a well-known antidepressant
Researchers have elucidated some of the links between the age-related loss of muscle (sarcopenia) and the age-related loss of bone (osteoporosis).
Restricting food access to an 8-hour window increased median lifespan in male mice by 12%. However, that might be due to
Doing something about aging seems to require action at the most basic genomic level. Here’s what’s been done there and in
A new study suggests a way to predict whether existing drugs can extend human lifespan. This method uses a network approach
Researchers have discovered a primate-specific piece of non-coding RNA that is linked to aging and makes senescence worse. The packing matters
A new study has used aging trajectories of various cell types to predict diseases such as Alzheimer’s and lung cancer [1].
Researchers have found that sustained expression of excess hypoxia-inducible factor (HIF)-1α leads to unwanted formation of blood vessels (angiogenesis) that destroys
NeuroAge Therapeutics announced Younger 2027, a six-month biological aging contest in which competitors are measured on a clinical-grade aging panel and